Abstract
Background:Cardiac troponins are frequently elevated in patients with end‐stage renal disease (ESRD) in the absence of acute myocardial ischemia. The cause and prognostic value of cardiac troponin elevations in such patients are controversial.
Hypothesis:The aims of this study were (1) to define the incidence of cTnT and cTnI elevations in patients with ESRD, (2) to evaluate the relationship between troponin elevations and leftventricularmass index (LVMI), and (3) to evaluate the prognostic value of elevations in cTnT and cTnI prospectively.
Methods:We included 129 patients with ESRD (71 men, age 44 ± 16 years) with no clinical evidence of coronary artery disease. All patients underwent cardiac examinations, including medical history, physical examination, electrocardiogram, andtransthoracic echocardiography. Left ventricular mass index was calculated and all patients were followed for 2 years.
Results:The cTnT concentration was > 0.03–0.1 ng/ml in 27 (20.9%) and > 0.1 ng/ml in 27 (20.9%) of the 129 patients. The cTnI concentration was > 0.5 ng/ml in 31 (24%) of 129 patients. Multiple logistic regression analysis identified LVMI (p < 0.001), diabetes (p = 0.001), and serum albumin level (p= 0.009) as a significant independent predictor for elevated cTnT. Left ventricular mass index was the only significant independent predictor for elevated cTnI (p = 0.002). There were 25 (19.4%) deaths during follow‐up. Multivariable analysis showed that elevation of cTnT and cTnI did not emerge as an independent predictor for death. Serum albumin level (p < 0.001) was the strongest predictor of mortality, followed by age (p = 0.002) and LVMI (p = 0.005).
Conclusions:Cardiac troponin T and I related significantly to the LVMI. The increased serum concentration of cardiac troponins probably originates from the heart; however, they are not independent predictors for prognosis.
Keywords: kidney, enzymes, hypertrophy, prognosis
Full Text
The Full Text of this article is available as a PDF (49.1 KB).
References
- 1. Frankel WL, Herold DA, Ziegler TW, Fitzgerald RL: Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996; 106: 118–123 [DOI] [PubMed] [Google Scholar]
- 2. Ooi DS, House AA: Cardiac troponin T in hemodialyzed patients. Clin Chem 1998; 44: 1410–1416 [PubMed] [Google Scholar]
- 3. Dierkes J, Domröse Westphal S, Ambrosch A, Bosselmann HP, Neumann KH: Cardiac troponin T predicts mortality in patients with end‐stage renal disease. Circulation 2000; 102: 1964–1969 [DOI] [PubMed] [Google Scholar]
- 4. Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, Ishikawa T, Kurokawa H, Hirano T, Kondo T, Nagamura Y, Ezaki K, Hishida H: Risk stratification using serum concentrations of cardiac troponin T in patients with end‐stage renal disease on chronic maintenance dialysis. Clin Chim Acta 2001; 312: 69–79 [DOI] [PubMed] [Google Scholar]
- 5. Beciani M, Tedesco A, Violante A, Cipriani S, Azzarito M, Sturniolo A, Spendiani G: Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: Prevalence and prognostic value. Nephrol Dial Transplant 2003; 18: 942–946 [DOI] [PubMed] [Google Scholar]
- 6. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, Vasavada BC, Sacchi TJ: Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long‐term hemodialysis. J Am Coll Cardiol 2001; 38: 991–998 [DOI] [PubMed] [Google Scholar]
- 7. McLaurin M.D., Apple FS, Voss EM, Herzog CA, Sharkey CW: Cardiac troponin I, cardiac troponin T and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43: 976–982 [PubMed] [Google Scholar]
- 8. Haller C, Zehelein J, Remppis A, Muller‐Bardorff M, Katus HA: Cardiac troponin T in patients with end‐stage renal disease. Absence of expression in truncal skeletal muscle. Clin Chem 1998; 44: 930–938 [PubMed] [Google Scholar]
- 9. Freda BJ, Tang WHW, Van Lente F, Peacock WF, Francis GS: Cardiac troponins in renal insufficiency. J Am Coll Cardiol 2002; 40: 2065–2071 [DOI] [PubMed] [Google Scholar]
- 10. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, Moatti N, Buisson C, Jacquot C: Factors associated with increased serum levels of cardiac troponins T and I in chronic hemodialysis patients: Chronic Hemodialysis and New Cardiac markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001; 16: 1452–1458 [DOI] [PubMed] [Google Scholar]
- 11. Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS: Troponin is related to left ventricular mass and predicts all‐cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002; 40: 68–75 [DOI] [PubMed] [Google Scholar]
- 12. Mockel M, Schindler R, Knorr L, Muller C, Heller G Jr, Stork TV, Frei U: Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: A 9‐month outcome analysis. Nephrol Dial Transplant 1999; 14: 1489–1495 [DOI] [PubMed] [Google Scholar]
- 13. Lang K, Schindler S, Forberger C, Stein G, Figulla HR: Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end‐stage renal failure. Clin Nephrol 2001; 56: 44–51 [PubMed] [Google Scholar]
- 14. Apple FS, Murakami MM, Pearce LA, Herzog CA: Predictive value of cardiac troponin I and T for subsequent death in end‐stage renal disease. Circulation 2002; 106: 2941–2945 [DOI] [PubMed] [Google Scholar]
- 15. Löwbeer C, Gutierrez A, Gustafsson SA, Norrman R, Hulting J, Seeberger A: Elevated cardiac troponin in peritoneal dialysis patients is associated with CRP and predicts all‐cause mortality and cardiac death. Nephrol Dial Transplant 2002; 17: 2178–2183 [DOI] [PubMed] [Google Scholar]
- 16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458 [DOI] [PubMed] [Google Scholar]
- 17. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH: Standardization of M‐mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222–1230 [DOI] [PubMed] [Google Scholar]
- 18. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS: Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false‐positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998; 44: 1919–1924 [PubMed] [Google Scholar]
- 19. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renalfailure. J AM Soc Nephrol 1999; 10: 1606–1615 [DOI] [PubMed] [Google Scholar]
- 20. Ooi DS, Veinot JP, Wells GA, House AA: Increased mortality in hemodialyzed patients with elevated serum troponin T: A one‐year outcome study. Clin Biochem 1999; 32: 647–652 [DOI] [PubMed] [Google Scholar]